MagVenture TMS Therapy ® was FDA cleared for depression in 2015 and the first company to receive FDA clearance for the 3-minute Express TMS ® – the shortest TMS treatment currently available.

ALPHARETTA, Ga. , March 17, 2021 /PRNewswire/ -- MagVenture, the Danish medical device company behind MagVenture TMS Therapy ® , introduces the MagVenture Flow Arm — a patent pending*, ...

MagVenture TMS Therapy System with Atlas Neuro Navigation MagVenture Atlas pulse electromagnetic transmitter Atlas Neuro Navigation patient reference sensors, coil sensor, and pointer ALPHARETTA ...

For people suffering from severe depression, the road to remission just became a lot shorter: The treatment is known as Transcranial Magnetic Stimulation (TMS), and MagVenture has now, as the only TMS ...

The US Food and Drug Administration (FDA) granted 510K clearance to market a new transcranial magnetic stimulation (TMS) device, the MagVita TMS Therapy system from MagVenture, for treatment of ...

MagVenture is a market-leading manufacturer of non-invasive Transcranial Magnetic Stimulation (TMS) systems worldwide. Privately owned with headquarters in Denmark, MagVenture has been pioneering ...

There are a number of treatments for depression, including drug options and transcranial magnetic stimulation (TMS). Now, one company is looking to provide a treatment option to help those suffering ...

MagVenture is a private, market-leading manufacturer of non-invasive TMS systems worldwide. Headquartered in Denmark, MagVenture has been pioneering leading-edge TMS solutions for more than 30 years.